-
Mashup Score: 70Intratumoral drug-releasing microdevices allow in situ high-throughput pharmaco phenotyping in patients with gliomas - 8 month(s) ago
Integrating drug-releasing microdevices into surgical practice provides comparative pharmacodynamic data to inform personalized therapy for gliomas.
Source: www.science.orgCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 1
A microdevice has been designed that can be implanted into tumors to conduct dozens of experiments at once to study the effects of new treatments on some of the hardest-to-treat brain cancers.
Source: news.harvard.eduCategories: Healthcare Professionals, Latest HeadlinesTweet-
WOW: #Microdevices implanted into #tumors offer new way to treat #braincancer https://t.co/z877OzCnsq via @Harvard Intratumoral drug-releasing microdevices allow in situ high-throughput pharmaco #phenotyping in patients with #gliomas https://t.co/nRD1Ik0KM6 @ScienceTM #glioma… https://t.co/0XvN7kwCxv https://t.co/Pparl9R3cX
-
-
Mashup Score: 1Modeling the Landscape of Histone-Mutant Pediatric High-Grade Gliomas: A Study in Partner Alterations - 9 month(s) ago
Summary:. Pediatric high-grade gliomas represent a group of deadly, heterogeneous tumors, often driven by histone mutations and the accumulation of clonal mutations, correlating with different tumor types, locations, and age of onset. In this study, McNicholas and colleagues present 16 in vivo models of histone-driven gliomas to investigate subtype-specific tumor biology and treatment options.See related article by McNicholas et al., p. 1592 (7).
Source: aacrjournals.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ICYMI from the July issue— In the Spotlight: Modeling the landscape of histone-mutant pediatric-high grade #gliomas: A study in partner alterations, by Evan Lubanszky and @CHawkinsLab. https://t.co/SF0y49IQzx @SickKidsNews @UofT https://t.co/30bAExzFdQ
-
-
Mashup Score: 3
An abstract is unavailable.
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In a breakthrough study, researchers presented encouraging progress in the treatment of #gliomas at #AACR2023. GD2-targeting CAR-T cells showed promising results, providing hope for potential transformative therapies: https://t.co/aCSe1xV3JL #breakthroughstudy https://t.co/aKFkJ4wbiC
-
-
Mashup Score: 0Unlocking AG-881: A New Era in Glioma Treatment (INDIGO Trial) - 9 month(s) ago
Vorasidenib (AG-881) is a promising targeted therapy for gliomas with IDH1 or IDH2 mutations. This novel approach could potentially revolutionize glioma treatment, reducing side effects and improving outcomes. Gliomas, specifically Grade 2 gliomas, are a complex group of brain tumors with varying prognoses dependi…
Source: oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Exciting advancements in oncology! AG-881 (Vorasidenib) is a potential game-changer in treating #gliomas, a type of #braintumor Read our in-depth article with an interview with Karan Dixit, MD, during #ASCO23. @NorthwesternMedicine https://t.co/P7uZQ4tby4
-
-
Mashup Score: 0Wolters Kluwer Health - 10 month(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
“H3K27M-mutated diffuse midline #gliomas are universally lethal central nervous system tumors in children and young adults,” observed Sneha Ramakrishna, MD. GD2-targeting chimeric antigen receptor (CAR)-T cells have evidence of benefit for patients. https://t.co/WITpzDblmy https://t.co/RMxc45uDQl
-
-
Mashup Score: 5Modeling the Landscape of Histone-Mutant Pediatric High-Grade Gliomas: A Study in Partner Alterations - 10 month(s) ago
Summary:. Pediatric high-grade gliomas represent a group of deadly, heterogeneous tumors, often driven by histone mutations and the accumulation of clonal mutations, correlating with different tumor types, locations, and age of onset. In this study, McNicholas and colleagues present 16 in vivo models of histone-driven gliomas to investigate subtype-specific tumor biology and treatment options.See…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
From the July issue— In the Spotlight: Modeling the landscape of histone-mutant pediatric-high grade #gliomas: A study in partner alterations, by Evan Lubanszky and @CHawkinsLab. https://t.co/DpbfjNJFOP @SickKidsNews @UofT https://t.co/K8AdDuYR98
-
-
Mashup Score: 2Incorporating Molecular Testing for Gliomas Into Clinical Practice - 10 month(s) ago
Craig Horbinski, MD, PhD, discusses the classification of gliomas based on histology and molecular features.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
WATCH: @CraigHorbinski, MD, PhD, discusses the classification of #gliomas based on histology and molecular features. #bcsm | @NUFeinbergMed https://t.co/rjf9ZFeGyR
-
-
Mashup Score: 2
Host Paul J. Camarata, MD, FAANS, and JNS Social Media Committee Member, Lior Elkaim, MD welcome neurosurgery leader Hugues Duffau, MD. Dr. Duffau discusses approaches to low-grade gliomas, amongst other topics.Hugues Duffau, MD, PhD, is Professor…
Source: BuzzsproutCategories: Latest Headlines, NeurologyTweet-
New episode of #ItsNotBrainSurgery, Hugues Duffau, MD, PhD, an expert in awake cognitive #neurosurgery, discusses his approach to low-grade #gliomas. #Podcast hosted by @pcamarata @LiorElkaim1. https://t.co/xgYC6QnVYw @CHU_Montpellier @KUHospital @mcgillu https://t.co/x0qapbF6hZ
-
-
Mashup Score: 0Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline - 11 month(s) ago
Abstract. In the 5th edition of the WHO CNS tumor classification (CNS5, 2021), multiple molecular characteristics became essential diagnostic criteria for many
Source: OUP AcademicCategories: General Medicine News, Latest HeadlinesTweet-
This #WorldBrainTumorDay, read @EANOassociation's guideline for "Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of #gliomas, glioneuronal and neuronal tumors": https://t.co/WbjslKjTPL https://t.co/1BOgezNVT6
-
A microdevice that releases drugs into tumors during resection is safe in humans and can be easily integrated into surgical workflows, allowing scientists to comprehensively capture tumor-specific drug responses in patients with #gliomas. @ScienceTM https://t.co/bwEYdXJTMa https://t.co/lztdcWMaB4